Last €317.69 EUR
Change Today +3.99 / 1.27%
Volume 97.0
RGO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 11:34 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for regeneron pharmaceuticals (RGO)

Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
4 Year
Trend
NET INCOME-104.5-221.8750.3424.4
Depreciation & Amortization19.731.136.941.2
DEPRECIATION & AMORTIZATION, TOTAL19.731.136.941.2
Amortization of Deferred Charges--3.921.623.0
Other Operating Activities4.17.9-304.887.4
Change in Accounts Receivable-17.5-21.1-590.1-198.7
Change in Inventories---14.1-28.9-48.0
Change in Accounts Payable7.650.011.0136.7
Change in Unearned Revenues158.2-40.3-41.1-28.0
Change in Other Working Capital-8.26.6-23.7-52.8
CASH FROM OPERATIONS99.2-141.7-74.6583.6
Capital Expenditure-99.7-57.2-49.3-156.3
Investments in Marketable & Equity Securities-331.4186.0-31.2-199.1
CASH FROM INVESTING-437.0128.5-81.1-355.5
Long-Term Debt Issued47.5391.1----
TOTAL DEBT ISSUED47.5391.1----
Long Term Debt Repaid-1.0-1.7-2.2-2.0
TOTAL DEBT REPAID-1.0-1.7-2.2-2.0
Issuance of Common Stock200.643.663.557.4
Repurchase of Common Stock-3.8-25.1-163.3-195.1
Other Financing Activities---23.74.3216.9
CASH FROM FINANCING243.3384.2-97.677.1
NET CHANGE IN CASH-94.5371.0-253.3305.3
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGO:GR €317.69 EUR +3.99

RGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexion Pharmaceuticals Inc $190.29 USD +4.37
Allergan Inc/United States $184.21 USD +0.84
BioMarin Pharmaceutical Inc $81.03 USD +6.02
UCB SA €65.61 EUR -0.77
Vertex Pharmaceuticals Inc $109.91 USD +1.82
View Industry Companies
 

Industry Analysis

RGO

Industry Average

Valuation RGO Industry Range
Price/Earnings 100.0x
Price/Sales 16.2x
Price/Book 17.1x
Price/Cash Flow 102.6x
TEV/Sales 15.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.